S&P 500   3,246.59 (+0.30%)
DOW   26,815.44 (+0.20%)
QQQ   265.39 (+0.47%)
AAPL   108.22 (+1.03%)
MSFT   203.19 (+1.30%)
FB   249.53 (+0.20%)
GOOGL   1,422.86 (+0.96%)
AMZN   3,019.79 (+0.66%)
NVDA   493.92 (+1.85%)
TSLA   387.79 (+1.95%)
BABA   269.73 (-1.18%)
CGC   14.27 (-2.26%)
GE   6.06 (-0.82%)
MU   49.47 (-0.76%)
AMD   75.82 (+1.46%)
T   28.04 (+0.61%)
F   6.66 (+0.30%)
ACB   5.20 (+0.58%)
GILD   62.25 (-1.33%)
NFLX   473.08 (+0.52%)
DIS   122.49 (-0.64%)
BAC   23.34 (+0.34%)
BA   146.05 (-3.39%)
S&P 500   3,246.59 (+0.30%)
DOW   26,815.44 (+0.20%)
QQQ   265.39 (+0.47%)
AAPL   108.22 (+1.03%)
MSFT   203.19 (+1.30%)
FB   249.53 (+0.20%)
GOOGL   1,422.86 (+0.96%)
AMZN   3,019.79 (+0.66%)
NVDA   493.92 (+1.85%)
TSLA   387.79 (+1.95%)
BABA   269.73 (-1.18%)
CGC   14.27 (-2.26%)
GE   6.06 (-0.82%)
MU   49.47 (-0.76%)
AMD   75.82 (+1.46%)
T   28.04 (+0.61%)
F   6.66 (+0.30%)
ACB   5.20 (+0.58%)
GILD   62.25 (-1.33%)
NFLX   473.08 (+0.52%)
DIS   122.49 (-0.64%)
BAC   23.34 (+0.34%)
BA   146.05 (-3.39%)
S&P 500   3,246.59 (+0.30%)
DOW   26,815.44 (+0.20%)
QQQ   265.39 (+0.47%)
AAPL   108.22 (+1.03%)
MSFT   203.19 (+1.30%)
FB   249.53 (+0.20%)
GOOGL   1,422.86 (+0.96%)
AMZN   3,019.79 (+0.66%)
NVDA   493.92 (+1.85%)
TSLA   387.79 (+1.95%)
BABA   269.73 (-1.18%)
CGC   14.27 (-2.26%)
GE   6.06 (-0.82%)
MU   49.47 (-0.76%)
AMD   75.82 (+1.46%)
T   28.04 (+0.61%)
F   6.66 (+0.30%)
ACB   5.20 (+0.58%)
GILD   62.25 (-1.33%)
NFLX   473.08 (+0.52%)
DIS   122.49 (-0.64%)
BAC   23.34 (+0.34%)
BA   146.05 (-3.39%)
S&P 500   3,246.59 (+0.30%)
DOW   26,815.44 (+0.20%)
QQQ   265.39 (+0.47%)
AAPL   108.22 (+1.03%)
MSFT   203.19 (+1.30%)
FB   249.53 (+0.20%)
GOOGL   1,422.86 (+0.96%)
AMZN   3,019.79 (+0.66%)
NVDA   493.92 (+1.85%)
TSLA   387.79 (+1.95%)
BABA   269.73 (-1.18%)
CGC   14.27 (-2.26%)
GE   6.06 (-0.82%)
MU   49.47 (-0.76%)
AMD   75.82 (+1.46%)
T   28.04 (+0.61%)
F   6.66 (+0.30%)
ACB   5.20 (+0.58%)
GILD   62.25 (-1.33%)
NFLX   473.08 (+0.52%)
DIS   122.49 (-0.64%)
BAC   23.34 (+0.34%)
BA   146.05 (-3.39%)
Log in

S&P 500 in ‘Fake It Til You Make It’ Melt-Up Trajectories

Monday, August 10, 2020 | Jea Yu
S&P 500 in ‘Fake It Til You Make It’ Melt-Up TrajectoriesThe S&P 500 (NYSEARCA: SPY) has made an impressive recovery off its March 23, 2020 pandemic lows at $218.26 taking a (-34%) plunge off the Feb. 18th highs of $339.08. The SPY has set up a perfect storm composed of bullish pup and mini pup formations across the three wider time frames daily, weekly and monthly. The markets are looking past COVID-19 while current economic indicators still wreak of recession. With narratives changing by the day amid growing tensions with China, election uncertainties, the second wave of COVID-19 hotspots threatening rollbacks and political gridlock over further federal economic aid to businesses and consumers, it’s hard to believe the SPY is nearing all-time highs again. Is there a disconnect with reality or is reality simply lagging the markets? Is the SPY faking it to buy enough time for a COVID-19 vaccine to receive an FDA approval?

Nasdaq 100 index Versus S&P 500 index

As impressive as the SPY recovery has been, the Nasdaq 100 index (NASDAQ: QQQ) surpassed its pre-COVID-19 all-time highs of $237.47 made on Feb. 18th. The QQQ first breached and made new highs on June 5th, retested on June 29th and peaked at all-time highs on Aug. 6th at $274.98. The Nasdaq has been powered by pandemic benefactors in the industries of information technology, biotechnology, internet and e-commerce while the SPY has been bogged down stocks in industries hit worst by the pandemic including travel and leisure, transportation, restaurants, manufacturing and industrials, banking and financials. The QQQ has been pre-dominantly fueled by the FANG stocks; Facebook (NASDAQ: FB) , Amazon (NASDAQ: AMZN) , Netflix (NASDAQ: NFLX) and Google (NASDAQ: GOOG) .

Narrative Impacts Sentiment Impacts Price

As of Aug. 9, 2020, COVID-19 cases reached 5 million cases in the U.S. and global infections surpassed 12 million cases. The market has shrugged off coronavirus figures, at least the negative ones. The overriding narrative is the Federal Reserve (Fed) put being firmly in place as markets perceive that Fed will come to the rescue with its quantitative easing (QE) infinity programs using COVID-19 relief as justification. In fact, the Fed balance sheet peaked at $4.6 trillion as the unwinding took it down to $3.8 trillion by Q3 2019. However, between Q4 2019 and June 2020, the Fed balance sheet as exploded to over $7 trillion and still rising. Many analysts believe all this liquidity is being pumped into equity markets. The concept of narrative impacts sentiment which moves price can be turned upside down when price gets extreme. Examples of this can be found with stocks like Tesla (NASDAQ: TSLA) , Shopify (NASDAQ: SHOP) and Zoom Video (NASDAQ: ZM) .

Fake it Til You Make It

The SPY is a laggard to the QQQ. Could the SPY melt-up be a way of buying time for an FDA approved COVID-19 vaccine? If that happens, the money could rush out of the QQQs and head into the SPY’s lagging epicenter industries like travel and leisure, lodging, consumer apparel, restaurants and transportation. On the flipside, if the QQQ’s peak out first, will money rotate into the SPY or kill off the momentum in SPY and pull it back down as well? Let’s take a look at the SPY charts.

S&P 500 in ‘Fake It Til You Make It’ Melt-Up Trajectories

SPY Price Trajectories

Using the rifle charts on monthly, weekly and daily time frames, we lay out the full near-term to longer-term playing field traders and investors. The monthly stochastic has crossed back up triggering a breakout with upper Bollinger Bands at $348.32 with the 5-period moving average (MA) support at $312.85. The weekly stochastic has been in a bullish stochastic mini pup since triggering the market structure low (MSL) above $263.33. The oscillation stretched through the 80-band and formed three stairstep mini pups with 5-period MA support at $324.36. The daily rifle chart also triggered a high band mini pup with 5-period MA support at $337.91 with upper BBs just shy of prior highs at the $339.08. This level will either be a double top or a springboard towards the upside trajectories of the $339.63 gatekeeper Fibonacci (fib) level, monthly and upper BBs at $348.32 and $357.60. If the daily stochastic peak out, then watch for the weekly and monthly 5-period MA supports to test before making another attempt to break prior highs. Rather than hard spikes, the bulls are best positioned during low-vol melt-ups that keep bears complacent and frustrated. Ultimately, the market will unveil the disconnect as time runs out triggering a fallout or an FDA vaccine approval rockets the SPY higher as the laggard sectors see panic buying.

Companies Mentioned in This Article

CompanyBeat the Market™ RankCurrent PricePrice ChangeDividend YieldP/E RatioConsensus RatingConsensus Price Target
Amazon.com (AMZN)1.7$3,019.79+0.7%N/A116.10Buy$3,358.77
Netflix (NFLX)1.5$473.08+0.5%N/A79.78Hold$493.90
Alphabet (GOOG)1.8$1,428.29+0.9%N/A31.41Buy$1,698.25
Facebook (FB)2.0$249.53+0.2%N/A30.47Buy$282.29
Invesco QQQ Trust (QQQ)1.0$265.39+0.5%0.61%N/AN/AN/A
Tesla (TSLA)1.5$387.79+2.0%N/A1,009.87Hold$201.53
Zoom Video Communications (ZM)1.3$464.98-7.1%N/A596.13Hold$358.08
Compare These Stocks  Add These Stocks to My Watchlist 

15 REITS Analysts Can't Stop Recommending

There are more than 200 publicly-traded real-estate investment trusts (REITs) that you can buy through your brokerage account. Given the sheer number of REITs, it can be hard to identify which real-estate stocks are going to outperform the market.

Fortunately, Wall Street's brightest minds have already done this for us. Every year, analyst issue approximately 4,000 distinct recommendations for REITs. Analysts don't always get their "buy" ratings right, but it's worth taking a hard look when several analysts from different brokerages and research firm are giving "strong buy" and "buy" ratings to the same REIT.

This slide show lists the 15 REITs that have the highest average analyst recommendations from Wall Street's equities research analysts over the last 12 months.

View the "15 REITS Analysts Can't Stop Recommending".

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.